Comparative genomic hybridization reveals changes in DNA-copy number in poor-risk neuroblastoma

Cancer Genetics and Cytogenetics

Volumn 125, Issue 2, 2001, Pages 125-130

  Vettenranta, Kim ^a   Aalto, Yan ^b   Wikström, Sakari ^a   Knuutila, Sakari ^b   Saarinen Pihkala, Ulla ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHILD; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA COPY NUMBER; FEMALE; HUMAN; HUMAN CELL; INFANT; MALE; NEUROBLASTOMA; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ANEUPLOIDY; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN; COMBINED MODALITY THERAPY; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; NEOPLASM STAGING; NEUROBLASTOMA; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035041497     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00366-6     Document Type: Article

References (19)

1. Saarinen U.M., Wikström S., Mäkipernaa A., Lanning M., Perkkio M., Hovi L., Rapola J., Sariola H. In vivo purging of bone marrow in children with poor-risk neuroblastoma for marrow collection and autologous bone marrow transplantation. J Clin Oncol. 14:1996;2791-2802.
2. Seeger R.C., Brodeur G.M., Sather H., Dalton A., Siegel S.E., Wong K.Y., Hammond D. Association of multiple copies of the NMYC oncogene with rapid progression of neuroblastomas. N Engl J Med. 313:1985;1111-1116.
3. Caron H., Van Sluis P., De Kraker J., Bokkerink J., Egeler M., Laureys G., Slater R., Westerveld A., Voute P.A., Versteeg R. Allelic loss of chromosome 1p as a predictor of unfavorable outcome on patients with neuroblastoma. N Engl J Med. 334:1996;225-229.
4. Bown N., Cotterill S., Lastowska M., O'Neill S., Pearson A.D., Plantaz D., Meddeb M., Danglot G., Brinkschmidt C., Christiansen H., Laureys G., Speleman F. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med. 340:1999;1954-1961.
5. Srivatsan E.S., Ying K.L., Seeger R.C. Deletion of chromosome 11 and 14q sequences in neuroblastoma. Genes Chromosomes Cancer. 7:1993;32-37.
6. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821.
7. Lastowska M., Nacheva E., McGuckin A., Curtis A., Grace C., Pearson A., Bown N. Comparative genomic hybridization study of primary neuroblastoma tumors. Genes Chromosom Cancer. 18:1997;162-169.
8. Brinkschmidt C., Christiansen H., Terpe H.J., Simon R., Boecker W., Lampert F., Stoerkel S. Comparative genomic hybridization (CGH) analysis of neuroblastomas - an important methodological approach in paediatric tumor pathology. J Pathol. 181:1997;394-400.
9. Plantaz D., Mohapatra G., Matthay K.K., Pellarin M., Seeger R.C., Feuerstein B.G. Gain in chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol. 150:1997;81-89.
10. El-Rifai W., Larramendy M.L., Björkqvist A.-M., Hemmer S., Knuutila S. Optimization of comparative genomic hybridization using fluorochrome conjugated to dCTP and dUTP nucleotides. Lab Invest. 77:1997;699-700.
11. Van Gele M., Van Roy Jauch A., Laureys G., Benoit Y., Schelfhout V., De Potter C.R., Brock P., Uyttebroeck A., Sciot R., Schuuring E., Versteeg R., Speleman F. Sensitive and reliable detection of genomic imbalances in human neuroblastoma using comparative genomic hybridisation analysis. Eur J Cancer. 12:1997;1979-1982.
12. Hirai M., Yoshida S., Kashiwagi H., Kawamura T., Ishikawa T., Kaneko M., Ohkawa H., Nakagawara A., Miwa M., Uchida K. 1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment. Genes Chromosomes Cancer. 25:1999;261-269.
13. Vandesompele J., Van Roy N., Van Gele M., Laureys G., Ambros P., Heimann P., Devalck C., Schuuring E., Brock P., Otten J., Gyselinck J., De Paepe A., Speleman F. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridisation. Genes Chromosomes Caner. 2:1998;141-152.
14. Brinkschmidt C., Poremba C., Christiansen H., Simon R., Schafer K.L., Terpe H.J., Lampert F., Boecker W., Dockhorn-Dworniczak B. Comparative genomic hybridisation and telomerase activity analysis identify two biologically different groups of 4s neuroblastoma. Br J Cancer. 12:1998;2223-2229.
15. Altura R.A., Maris J.M., Li H., Boyett J.M., Brodeur G.M., Look A.T. Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridisation. Genes Chromosomes Cancer. 3:1997;176-184.
16. Schröck E., Thiel G., Lozanova T., du Manoir S., Meffert M.C., Jauch A., Speicher M.R., Nurnberg P., Vogel S., Janisch W.et al. Comparative genomic hybridisation of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol. 144:1994;1203-1218.
17. Weber R.G., Sommer C., Albert F.K., Kiessling M., Cremer T. Clinically distints subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Lab Invest. 74:1996;108-119.
18. Schmidt H., Wurl P., Taubert H., Meye A., Bache M., Holzhausen H.J., Hinze R. Genomic imbalances of 7p and 17q in malignant peripheral nerve sheat tumors are clinically relevant. Genes Chromosomes Cancer. 25:1999;205-211.
19. Nishizaki T., Harada K., Kubota H., Ozaki S., Ito H., Sasaki K. Genetic alterations in pediatric medulloblastomas detected by comparative genomic hybridization. Pediatr Neurosurg. 31:1999;27-32.